21 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
and may take an extended period of time because of the limited talent pool in our industry due to the breadth of skills and experience required
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
and may take an extended period of time because of the limited talent pool in our industry due to the breadth of skills and experience required
6-K
EX-99.2
XRTX
XORTX Therapeutics Inc
30 May 23
Notice of Annual & Special Meeting of Shareholders
7:00am
of a number of factors (which include merit, talent, experience, expertise, leadership capabilities, innovative thinking and strategic agility
6-K
EX-99.3
mibdu52fgm5a 8vuiejm
3 Apr 23
Consolidated Financial Statements
6:05am
424B4
yh751 gvuf2
5 Oct 22
Prospectus supplement with pricing info
5:24pm
POS AM
17f8huil60b83r guka
29 Sep 22
Prospectus update (post-effective amendment)
9:49pm
F-1/A
x06ifqyrbh1g9a
21 Sep 22
Registration statement (foreign) (amended)
4:20pm
F-1
m1m90 myrw74qjtv
8 Sep 22
Registration statement (foreign)
1:02pm
DRS
zzheo
15 Aug 22
Draft registration statement
12:00am
6-K
EX-99.2
mlevg 6440x4s
30 Jun 22
Notice of Annual & Special Meeting of Shareholders
6:00am
20-F
x3qk43y
3 May 22
Annual report (foreign)
5:29pm
6-K
EX-99.1
o7ajbqmbsgjgh7
13 Apr 22
Current report (foreign)
7:23am
6-K
EX-99.2
c5r tqu67r
23 Nov 21
Notice of Annual & Special Meeting of Shareholders
7:17am
424B4
2xlzh7o3
14 Oct 21
Prospectus supplement with pricing info
4:30pm
F-1/A
yof8c2z82t oih2
4 Oct 21
Registration statement (foreign) (amended)
12:00am
F-1/A
1g0nqi1b55v90q9ljer
16 Sep 21
Registration statement (foreign) (amended)
5:16pm
F-1
bio3zd6ar49k7nwqk zr
11 Aug 21
Registration statement (foreign)
9:55pm
DRS/A
74au1i19a7hzr
21 Jul 21
Draft registration statement (amended)
12:00am